Jeeyun Lee
Clinical trials sponsored by Jeeyun Lee, explained in plain language.
-
New drug duo offers hope for hard-to-treat stomach cancer
Disease control Recruiting nowThis study tests a combination of two targeted drugs, trastuzumab deruxtecan (T-DXd) and afatinib, in people with advanced stomach cancer that has low levels of a protein called HER2. The goal is to see if the combination is safe and works better than current treatments. About 61…
Phase: PHASE1, PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
New hope for advanced stomach cancer: targeted drug combo trial launches
Disease control Recruiting nowThis study tests whether combining targeted therapies with or without an immunotherapy drug can shrink advanced stomach tumors before surgery and improve long-term outcomes. About 50 adults with HER2-positive stomach cancer that cannot be removed right away will receive treatment…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New hope for stomach cancer patients with MET gene amplification?
Disease control Recruiting nowThis study tests a combination of two drugs, savolitinib and durvalumab, in people with advanced stomach cancer that has a specific genetic change called MET amplification. Participants must have already tried at least one prior chemotherapy that stopped working. The goal is to s…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 26, 2026 09:35 UTC